Monitoring bone mineral density during antiresorptive treatment for osteoporosis

被引：14

作者：

Compston, Juliet ^{[1
]}

机构：

[1] Univ Cambridge, Sch Clin Med, Cambridge CB2 0SP, England

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2009年 / 338卷

关键词：

POSTMENOPAUSAL OSTEOPOROSIS; FRACTURE; RISK; REDUCTION; THERAPY; WOMEN;

D O I：

10.1136/bmj.b1276

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

收藏

页数：3

相关论文

共 12 条

[1]

Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data [J].

Bell, Katy J. L. ;

Hayen, Andrew ;

Macaskill, Petra ;

Irwig, Les ;

Craig, Jonathan C. ;

Ensrud, Kristine ;

Bauer, Douglas C. .

BMJ-BRITISH MEDICAL JOURNAL, 2009, 338 :1553

[2]

Risk of fracture among women who lose bone density during treatment with alendronate. The Fracture Intervention Trial [J].

Chapurlat, RD ;

Palermo, L ;

Ramsay, P ;

Cummings, SR .

OSTEOPOROSIS INTERNATIONAL, 2005, 16 (07) :842-848

[3]

The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: A randomized controlled [J].

Clowes, JA ;

Peel, NFA ;

Eastell, R .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (03) :1117-1123

[4]

Compliance with osteoporosis therapy is the weakest link [J].

Compston, Juliet E. ;

Seeman, Ego .

LANCET, 2006, 368 (9540) :973-974

[5]

Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs [J].

Cummings, SR ;

Karpf, DB ;

Harris, F ;

Genant, HK ;

Ensrud, K ;

LaCroix, AZ ;

Black, DM .

AMERICAN JOURNAL OF MEDICINE, 2002, 112 (04) :281-289

[6]

*ISCD, OFF POS 2007

[7]

Factors affecting short-term bone density precision assessment and the effect on patient monitoring [J].

Leslie, William D. .

JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 (02) :199-204

[8]

Longitudinal progression of fracture prevalence through a population of postmenopausal women with osteoporosis [J].

Lindsay, R ;

Pack, S ;

Li, ZQ .

OSTEOPOROSIS INTERNATIONAL, 2005, 16 (03) :306-312

[9]

*NOF, 2008, NEW CLIN GUID PREV T

[10]

Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy [J].

Sarkar, S ;

Mitlak, BH ;

Wong, MM ;

Stock, JL ;

Black, DM ;

Harper, KD .

JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (01) :1-10